
0.9806 Delayed Data As of May 23 | ![]() Today’s Change | 0.84 Today|||52-Week Range 6.07 | -65.95% Year-to-Date |
The 4 analysts offering 12-month price forecasts for Zynerba Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 9.00 and a low estimate of 1.00. The median estimate represents a +613.85% increase from the last price of 0.98.
The current consensus among 5 polled investment analysts is to Buy stock in Zynerba Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.